Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells |
Ye, Dong-Jin
(College of Pharmacy, Chung-Ang University)
Kwon, Yeo-Jung (College of Pharmacy, Chung-Ang University) Shin, Sangyun (College of Pharmacy, Chung-Ang University) Baek, Hyoung-Seok (College of Pharmacy, Chung-Ang University) Shin, Dong-Won (College of Pharmacy, Chung-Ang University) Chun, Young-Jin (College of Pharmacy, Chung-Ang University) |
1 | Suzuki, M., Ishida, H., Shiotsu, Y., Nakata, T., Akinaga, S., Takashima, S., Utsumi, T., Saeki, T. and Harada, N. (2009) Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients. J. Steroid Biochem. Mol. Biol. 113, 195-201. DOI |
2 | Suzuki, T., Miki, Y., Nakamura, Y., Ito, K. and Sasano, H. (2011) Steroid sulfatase and estrogen sulfotransferase in human carcinomas. Mol. Cell. Endocrinol. 340, 148-153. DOI |
3 | Im, H. J., Park, N. H., Kwon, Y. J., Shin, S., Kim, D. and Chun, Y. J. (2012) Bacterial lipopolysaccharides induce steroid sulfatase expression and cell migration through IL-6 pathway in human prostate cancer cells. Biomol. Ther. (Seoul) 20, 556-561. DOI |
4 | Jia, Y., Zeng, Z. Z., Markwart, S. M., Rockwood, K. F., Ignatoski, K. M., Ethier, S. P. and Livant, D. L. (2004) Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res. 64, 8674-8681. DOI |
5 | Kim, C. W., Go, R. E. and Choi, K. C. (2015) Treatment of BG-1 ovarian cancer cells expressing estrogen receptors with lambdacyhalothrin and cypermethrin caused a partial estrogenicity via an estrogen receptor-dependent pathway. Toxicol. Res. 31, 331-337. DOI |
6 | Lee, S. H., Yang, Y. J., Kim, K. M. and Chung, B. C. (2003) Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer. Cancer Lett. 201, 121-131. DOI |
7 | Lahlou, H. and Muller, W. J. (2011) -integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Res. 13, 229. DOI |
8 | Lamb, L. E., Zarif, J. C. and Miranti, C. K. (2011) The androgen receptor induces integrin to promote prostate tumor cell survival via and Bcl-xL Independently of PI3K signaling. Cancer Res. 71, 2739-2749. DOI |
9 | Lee, K. M., Ju, J. H., Jang, K., Yang, W., Yi, J. Y., Noh, D. Y. and Shin, I. (2012) CD24 regulates cell proliferation and transforming growth factor -induced epithelial to mesenchymal transition through modulation of integrin stability. Cell. Signal. 24, 2132-2142. DOI |
10 | Hynes, R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687. DOI |
11 | Wilson, S. H., Ljubimov, A. V., Morla, A. O., Caballero, S., Shaw, L. C., Spoerri, P. E., Tarnuzzer, R. W. and Grant, M. B. (2003) Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through integrin and PI 3-kinase. Invest. Ophthalmol. Vis. Sci. 44, 1704-1715. DOI |
12 | Utsumi, T., Yoshimura, N., Takeuchi, S., Maruta, M., Maeda, K. and Harada, N. (2000) Elevated steroid sulfatase expression in breast cancers. J. Steroid Biochem. Mol. Biol. 73, 141-145. DOI |
13 | van der Flier, A. and Sonnenberg, A. (2001) Function and interactions of integrins. Cell Tissue Res. 305, 285-298. DOI |
14 | Wang, J. G., Miyazu, M., Xiang, P., Li, S. N., Sokabe, M. and Naruse, K. (2005) Stretch-induced cell proliferation is mediated by FAK-MAPK pathway. Life Sci. 76, 2817-2825. DOI |
15 | Miyoshi, Y., Ando, A., Hasegawa, S., Ishitobi, M., Taguchi, T., Tamaki, Y. and Noguchi, S. (2003) High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin. Cancer Res. 9, 2288-2293. |
16 | Wood, P. M., Woo, L. W., Labrosse, J. R., Thomas, M. P., Mahon, M. F., Chander, S. K., Purohit, A., Reed, M. J. and Potter, B. V. (2010) Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino] methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities. Chem. Med. Chem. 5, 1577-1593. DOI |
17 | Woodward, T. L., Mienaltowski, A. S., Modi, R. R., Bennett, J. M. and Haslam, S. Z. (2001) Fibronectin and the integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142, 3214-3222. DOI |
18 | Yamamoto, T., Kitawaki, J., Urabe, M., Honjo, H., Tamura, T., Noguchi, T., Okada, H., Sasaki, H., Tada, A., Terashima, Y., Nakamura, J. and Yoshihama, M. (1993) Estrogen productivity of endometrium and endometrial cancer tissue; influence of aromatase on proliferation of endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 44, 463-468. DOI |
19 | Liapis, H., Flath, A. and Kitazawa, S. (1996) Integrin expression by bone-residing breast cancer metastases. Diagn. Mol. Pathol. 5, 127-135. DOI |
20 | Meng, X. N., Jin, Y., Yu, Y., Bai, J., Liu, G. Y., Zhu, J., Zhao, Y. Z., Wang, Z., Chen, F., Lee, K. Y. and Fu, S. B. (2009) Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br. J. Cancer 101, 327-334. DOI |
21 | Monaghan, E., Gueorguiev, V., Wilkins-Port, C. and McKeown-Longo, P. J. (2004) The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts. J. Biol. Chem. 279, 1400-1407. DOI |
22 | Morozevich, G., Kozlova, N., Cheglakov, I., Ushakova, N. and Berman, A. (2009) Integrin controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity. Cell Cycle 8, 2219-2225. DOI |
23 | Muller, J. M., Krauss, B., Kaltschmidt, C., Baeuerle, P. A. and Rupec, R. A. (1997) Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 272, 23435-23439. DOI |
24 | Nam, J. M., Onodera, Y., Bissell, M. J. and Park, C. C. (2010) Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin and fibronectin. Cancer Res. 70, 5238-5248. DOI |
25 | Noh, H., Hong, S. and Huang, S. (2013) Role of urokinase receptor in tumor progression and development. Theranostics 3, 487-495. DOI |
26 | Cheung, P. F., Wong, C. K., Ip, W. K. and Lam, C. W. (2008) FAK-mediated activation of ERK for eosinophil migration: a novel mechanism for infection-induced allergic inflammation. Int. Immunol. 20, 353-363. DOI |
27 | Yang, W., Zhang, Y., Li, Y., Wu, Z. and Zhu, D. (2007) Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 pathway and is antagonized by insulin-like growth factor 1. J. Biol. Chem. 282, 3799-3808. |
28 | Ahn, H. N., Jeong, S. Y., Bae, G. U., Chang, M., Zhang, D., Liu, X., Pei, Y., Chin, Y. W., Lee, J., Oh, S. R. and Song, Y. S. (2014) Selective estrogen receptor modulation by Larrea nitida on MCF-7 cell proliferation and immature rat uterus. Biomol. Ther. (Seoul) 22, 347-354. DOI |
29 | Baglietto, L., Severi, G., English, D. R., Krishnan, K., Hopper, J. L., McLean, C., Morris, H. A., Tilley, W. D. and Giles, G. G. (2010) Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 19, 492-502. DOI |
30 | Cai, C., Chen, S., Ng, P., Bubley, G. J., Nelson, P. S., Mostaghel, E. A., Marck, B., Matsumoto, A. M., Simon, N. I., Wang, H., Chen, S. and Balk, S. P. (2011) Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res. 71, 6503-6513. DOI |
31 | Chumsri, S., Howes, T., Bao, T., Sabnis, G. and Brodie, A. (2011) Aromatase, aromatase inhibitors, and breast cancer. J. Steroid Biochem. Mol. Biol. 125, 13-22. DOI |
32 | Cid, M. C., Esparza, J., Schnaper, H. W., Juan, M., Yague, J., Grant, D. S., Urbano-Marquez, A., Hoffman, G. S. and Kleinman, H. K. (1999) Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function. Angiogenesis 3, 271-280. DOI |
33 | Abulafia, O., Lee, Y. C., Wagreich, A., Economos, K., Serur, E. and Nacharaju, V. L. (2009) Sulfatase activity in normal and neoplastic endometrium. Gynecol. Obstet. Invest. 67, 57-60. DOI |
34 | Purohit, A. and Foster, P. A. (2012) Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers. J. Endocrinol. 212, 99-110. DOI |
35 | Oloumi, A., McPhee, T. and Dedhar, S. (2004) Regulation of E-cadherin expression and -catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim. Biophys. Acta 1691, 1-15. DOI |
36 | Pankov, R. and Yamada, K. M. (2002) Fibronectin at a glance. J. Cell Sci. 115, 3861-3863. DOI |
37 | Park, S. H., Cheung, L. W., Wong, A. S. and Leung, P. C. (2008) Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor . Mol. Endocrinol. 22, 2085-2098. DOI |
38 | Rasmussen, L. M., Zaveri, N. T., Stenvang, J., Peters, R. H. and Lykkesfeldt, A. E. (2007) A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer. Breast Cancer Res. Treat. 106, 191-203. DOI |
39 | Rathinam, R. and Alahari, S. K. (2010) Important role of integrins in the cancer biology. Cancer Metastasis Rev. 29, 223-237. DOI |
40 | Rausch, L., Green, C., Steinmetz, K., LeValley, S., Catz, P., Zaveri, N., Schweikart, K., Tomaszewski, J. and Mirsalis, J. (2011) Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator. Cancer Chemother. Pharmacol. 67, 1341-1352. DOI |
41 | Reed, M. J., Purohit, A., Woo, L. W., Newman, S. P. and Potter, B. V. (2005) Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 26, 171-202. DOI |
42 | Gera, J. F., Mellinghoff, I. K., Shi, Y., Rettig, M. B., Tran, C., Hsu, J. H., Sawyers, C. L. and Lichtenstein, A. K. (2004) AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J. Biol. Chem. 279, 2737-2746. DOI |
43 | Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M. and Forbes, J. F. (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 11, 1135-1141. DOI |
44 | Dent, S. F., Gaspo, R., Kissner, M. and Pritchard, K. I. (2011) Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res. Treat. 126, 295-310. DOI |
45 | Evans, T. R., Rowlands, M. G., Law, M. and Coombes, R. C. (1994) Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. Br. J. Cancer 69, 555-561. DOI |
46 | Evans, T. R., Rowlands, M. G., Silva, M. C., Law, M. and Coombes, R. C. (1993) Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer. J. Steroid Biochem. Mol. Biol. 44, 583-587. DOI |
47 | Fournier, M. A. and Poirier, D. (2009) Estrogen formation in endometrial and cervix cancer cell lines: Involvement of aromatase, steroid sulfatase and -hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Mol. Cell. Endocrinol. 301, 142-145. DOI |
48 | Guo, W. and Giancotti, F. G. (2004) Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816-826. DOI |
49 | Haning, R. V., Hackett, R. J., Boothroid, R. I. and Canick, J. A. (1990) Steroid sulfatase activity in the human ovarian corpus luteum, stroma and follicle: comparison to activity in other tissues and the placenta. J. Steroid Biochem. 36, 175-179. DOI |
50 | Rolli, M., Fransvea, E., Pilch, J., Saven, A. and Felding-Habermann, B. (2003) Activated integrin cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl . Acad. Sci. U.S.A. 100, 9482-9487. DOI |
51 | Sato, R., Suzuki, T., Katayose, Y., Miura, K., Shiiba, K., Tateno, H., Miki, Y., Akahira, J., Kamogawa, Y., Nagasaki, S., Yamamoto, K., Ii, T., Egawa, S., Evans, D. B., Unno, M. and Sasano, H. (2009) Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. Cancer Res. 69, 914-922. DOI |
52 | Schlaepfer, D. D., Hanks, S. K., Hunter, T. and van der Geer, P. (1994) Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786-791. DOI |
53 | Schlaepfer, D. D. and Hunter, T. (1996) Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell. Biol. 16, 5623-5633. DOI |
54 | Sisci, D., Middea, E., Morelli, C., Lanzino, M., Aquila, S., Rizza, P., Catalano, S., Casaburi, I., Maggiolini, M. and Ando, S. (2010) -Estradiol enhances integrin subunit gene expression through -Sp1 interaction and reduces cell motility and invasion of -positive breast cancer cells. Breast Cancer Res. Treat. 124, 63-77. DOI |